|
KPNA4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.34189999999135E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.602450E-04 |
| Normal-vs-Stage2 |
2.984200E-02 |
| Normal-vs-Stage3 |
4.591300E-04 |
| Normal-vs-Stage4 |
1.243760E-02 |
| Stage1-vs-Stage2 |
9.780000E-01 |
| Stage1-vs-Stage3 |
4.820000E-01 |
| Stage1-vs-Stage4 |
9.260400E-01 |
| Stage2-vs-Stage3 |
6.714800E-01 |
| Stage2-vs-Stage4 |
9.304200E-01 |
| Stage3-vs-Stage4 |
5.515800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.26989999999994E-05 |
| Normal-vs-AfricanAmerican |
3.84130000000704E-05 |
| Normal-vs-Asian |
6.372600E-01 |
| Caucasian-vs-AfricanAmerican |
1.339370E-01 |
| Caucasian-vs-Asian |
4.873800E-01 |
| AfricanAmerican-vs-Asian |
1.703580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.79352999999383E-05 |
| Normal-vs-Female |
2.439100E-03 |
| Male-vs-Female |
2.703000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.133400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.983110E-03 |
| Normal-vs-Age(61-80Yrs) |
1.81579999999348E-05 |
| Normal-vs-Age(81-100Yrs) |
3.624200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.440200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.231800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.129600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.817840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.700580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.940000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.852400E-01 |
| Normal-vs-Grade 2 |
4.381900E-03 |
| Normal-vs-Grade 3 |
2.28660000001213E-06 |
| Normal-vs-Grade 4 |
7.201800E-03 |
| Grade 1-vs-Grade 2 |
5.591600E-01 |
| Grade 1-vs-Grade 3 |
2.739200E-01 |
| Grade 1-vs-Grade 4 |
3.843800E-01 |
| Grade 2-vs-Grade 3 |
6.756400E-02 |
| Grade 2-vs-Grade 4 |
4.406600E-01 |
| Grade 3-vs-Grade 4 |
7.228400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.255300E-03 |
| Normal-vs-ccB subtype |
4.502100E-03 |
| ccA subtype-vs-ccB subtype |
8.722200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.082030E-03 |
| Normal-vs-N1 |
3.860400E-01 |
| N0-vs-N1 |
7.460000E-01 |
|
|
